Glenmark initiates Phase 3 clinical trials on antiviral Favipiravir for COVID-19 patients in India
Glenmark is the first company in India to initiate Phase 3 clinical trials on Favipiravir for COVID-19 patients in India
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.